About Mayne Pharma
At Mayne Pharma we are focused on keeping our promises to patients for better medicines and a better tomorrow.
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals. We offer patients better, safe and more accessible medicines.
Mayne Pharma has a 40-year track record of innovation and success in developing oral drug delivery systems. These technologies have been successfully commercialized in numerous products that continue to be marketed around the world.
With roots traced to FH Faulding and Co, we are one of the largest and most prominent public companies headquartered in South Australia.
A technology driven company, Mayne Pharma has expertise in complex oral and topical dose forms including highly potent compounds, modified release products and poorly soluble compounds. The business is supported by over 900 staff globally with more than 200 scientists.